Impel NeuroPharma, Inc., is a privately-held, Seattle-based company devoted to creating life-changing, innovative therapies for central nervous system (CNS) diseases. Impel's products are based on a novel nasal drug delivery platform, the POD™ device, that administers drug to the upper nasal cavity in a consistent and predictable manner.

Pharmaceutical

Impel Pharmaceuticals

Adrian Adams

Kelly Fitzgerald

Tina Mitsialis

Scott Patry

Michael Krause

Khalid Nisar

Beth Lydin

Chris Jeffries

Rajiv Amin

Shelley di Tommaso

Karen Bodin-Rincon

Brett Downing

John Hoekman

Rigo Canal

Michael Malafronte

Leonard S. Paolillo

Jen Berman

The board of directors at Impel Pharmaceuticals has a history of experience in the accounting field from companies such as Gilead Sciences and Caesars Entertainment Corporation. The board is currently chaired by an independent board member from Impel NeuroPharma.

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at Impel Pharmaceuticals

Leadership Team

CEO and Executive Team